| Dynavax: HEPLISAV BLA Submission On Track For May 2012 - Seeking Alpha |
|
|
Seeking Alpha In 2008, there were approximately 750000 end-stage renal disease, or ESRD, patients in the United States and major European markets, with approximately 150000 new patients added annually." To this end, the company has announced that it will file a |